USCIS exempts pandemic aid from immigration public charge rule | Inquirer
 
 
 
 
 
 

USCIS exempts pandemic aid from immigration public charge rule

File photo shows Calfifornia Governor Gaving Newsom and Attorney General Xavier Beccera challenging Trump administration’s immigration public charge rule. AP FILE PHOTO

On March 13, US Citizenship and Immigration Services (USCIS) issued a public alert stating that seeking treatment for COVID-19 related health issues would not negatively affect any alien as part of a future public charge determination.

In a March 27 alert, the agency further clarified:  “The Public Charge rule does not restrict access to testing, screening, or treatment of communicable diseases, including COVID-19. In addition, the rule does not restrict access to vaccines for children or adults to prevent vaccine-preventable diseases.”

The March 27 advisory also stated that there might be an exception with regard to receipt of certain cash and non-cash public benefits.  “The rule requires USCIS to consider the receipt of certain cash and non-cash public benefits, including those that may be used to obtain testing or treatment for COVID-19 in a public charge inadmissibility determination, and for purposes of a public benefit  condition applicable to certain nonimmigrants seeking an extension of stay or change of status.”

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The alert can be read here in its entirety: https://www.uscis.gov/greencard/public-charge

Want stories like this delivered straight to your inbox? Stay informed. Stay ahead. Subscribe to InqMORNING

Don't miss out on the latest news and information.
TAGS: immigration US, pandemic, public charge rule, USCIS
For feedback, complaints, or inquiries, contact us.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.




This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.